Amplimexon imexon: Phase I data

In a Phase I trial in 49 patients, Amplimexon was well tolerated and the maximum tolerated dose was 875 mg/m 2/day. Patients received Amplimexon doses ranging from 20-1000 mg/m 2/day as a 30 minute in...